Symbol="HOWL"
AssetType="Common Stock"
Name="Werewolf Therapeutics Inc"
Description="Werewolf Therapeutics, Inc., a biopharmaceutical company, develops therapies designed to boost the body's immune system for the treatment of cancer. The company is headquartered in Cambridge, Massachusetts."
CIK="1785530"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="200 TALCOTT AVENUE, 2ND FLOOR, WATERTOWN, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="89385000"
EBITDA="-42328000"
PERatio="None"
PEGRatio="None"
BookValue="3.328"
DividendPerShare="0"
DividendYield="0"
EPS="-1.41"
RevenuePerShareTTM="0.758"
ProfitMargin="-1.651"
OperatingMarginTTM="-1.775"
ReturnOnAssetsTTM="-0.153"
ReturnOnEquityTTM="-0.33"
RevenueTTM="24798000"
GrossProfitTTM="-37360000"
DilutedEPSTTM="-1.41"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.948"
AnalystTargetPrice="13"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="6.61"
PriceToBookRatio="0.42"
EVToRevenue="0.157"
EVToEBITDA="1.17"
Beta="0.157"
num_52WeekHigh="7.51"
num_52WeekLow="1.39"
num_50DayMovingAverage="2.99"
num_200DayMovingAverage="2.715"
SharesOutstanding="35611400"
DividendDate="None"
ExDividendDate="None"
symbol="HOWL"
open="2.48"
high="2.50"
low="2.40"
price="2.46"
volume="15969.00"
latest_trading_day="2023-08-21"
previous_close="2.51"
change="-0.05"
change_percent="-1.9920%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="45"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="55"
Volume_recent_avg="42374"
Change_recent_avg="-0.02"
Delta_recent_avg="0.24"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.99"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="55"
Aroon_momentum_negative="45"
image_negative_thumbnail_id_1="504"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0101.jpeg"
image_negative_thumbnail_id_2="96"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0080.jpeg"
image_neutral_thumbnail_id_1="544"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0055.jpeg"
image_neutral_thumbnail_id_2="576"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0023.jpeg"
image_positive_thumbnail_id_1="682"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0026.jpeg"
image_positive_thumbnail_id_2="609"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0099.jpeg"
image_professor_thumbnail_id_1="1185"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0019.jpeg"
image_professor_thumbnail_id_2="1176"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0010.jpeg"
